Cancer and the Statistic of One
Rapid medical advances, as well as growing volumes of health and mortality data, are transforming cancer risk assessment. RGA's Neil Parkin explores our deepening understanding and insurance implications.
Impaired Risk Review: What You Don't Know WILL Hurt You
One of the toughest situations for an underwriter is the case that seems to have literally fallen off the cliff. A condition that is significant, that is being followed, and that does have mortality consequences suddenly has no notes of any recency for six months or more. Follow-up that appeared to be favorable virtually disappears, and the underwriter is left with guessing that things have continued to go reasonably well. Or not...
Milliman Risk Score 2.0 – Stratifying Mortality Risk Using Prescription Drug Information
Munich Re assessed the Milliman Rx Risk Score, a predictive modeling tool developed and owned by Milliman that assesses mortality risk using an individual’s prescription drug information. Insurers considering prescription- drug-based scores should begin with a retrospective validation study on their own experience data.
Alcohol Risk in Perspective
The publication by The Lancet recently of an article discussing the risk to health posed by alcohol seems to have put paid for all time to the notion that moderate drinking does no harm or is even ‘good for you’. It has thus caused a bit of a stir in some quarters.
Be Kind to Your Genes: An Insurance Perspective on the Fast-Growing Field of Epigenetics
Eat your vegetables. Stay active. Avoid smoking. Keep out of the sun. Patients have been hearing this good advice from their doctors for a long time. Now, researchers are uncovering new evidence that our lifestyle choices can measurably influence mortality risk at a genetic level. Learn more about the emerging science of epigenetics in a two-part interview and the webinar “Epigenetics and Liquid Biopsies: Fact, Fiction or Both.”
SCOR Housecalls: Chronic Granulomatous Disease
What is Chronic Granulomatous Disease, and what are the mortality implications?
LexisNexis Risk Classifier – Stratifying Mortality Risk Using Alternative Data Sources
Munich Re assessed LexisNexis Risk Classifier, a predictive modeling tool developed and owned by LexisNexis Risk Solutions, Inc. that accurately stratifies mortality risk using public records, consumer credit history and motor vehicle history. Insurers considering alternative data-based mortality scores should begin with a retrospective validation study on their own experience data.
Cancer Deaths Fall to Lowest Rate in Decades as Smoking Declines
Fewer Americans are getting cancer, and more of those who do are surviving the disease, according to a new study.
Cancer Risks: Are We Getting Them Right?
Researching cancer mortality over the past few months has proved to be a bit of an eye-opener, and in three ways: firstly the level of excess mortality seen in a number of cancers, secondly the duration over which an extra risk persists, and thirdly that excess mortality may extend over a considerable period.